Pharmaceuticals in water
This article was originally published in The Tan Sheet
Executive Summary
The House passes a bill to authorize appropriations for water pollution control and asks the Environmental Protection Agency to convene a task force for keeping disposed pharmaceuticals and personal care products out of water systems. The task force - with members to include the EPA administrator and FDA commissioner or their designees - must also devise a strategy for educating the public on its recommendations. Rep. Candice Miller, R-Mich., said March 12 she offered H.R. 1262 as an amendment to the Water Quality Investment Act of 2009 because medical facilities lack uniform standards for disposing unused Rx and nonprescription medicine, often flushing them down toilets. The bill passed the House March 12 and is currently in the Senate Committee on Environment and Public Works
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.